Layout 1

Interpretation: First Nations and Métis adults responded robustly to ASO3-adjuvanted pandemic (H1N1) 2009 vaccine. Virtually all participants showed protective titres, including those with chronic health conditions. Trial registration: ClinicalTrials.gov trial register no. NCT.01001026. Abstract

Bibliographic Details
Main Authors: MD Ethan Rubinstein, MD Gerald Predy, MD Laura Sauvé, MD Greg W Hammond, MD Fred Aoki, MD Chris Sikora, PhD Yan Li, MD Barbara Law, MD Scott Halperin, MD David Scheifele, David Scheifele, Scott Halperin, Gerald Predy, Chris Sikora, Fred Aoki, Dr David Scheifele
Other Authors: The Pennsylvania State University CiteSeerX Archives
Format: Text
Language:English
Subjects:
First Nations
Online Access:http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1069.2421
http://cirnetwork.ca/wp-content/uploads/2013/11/Article11.pdf
Description
Summary:Interpretation: First Nations and Métis adults responded robustly to ASO3-adjuvanted pandemic (H1N1) 2009 vaccine. Virtually all participants showed protective titres, including those with chronic health conditions. Trial registration: ClinicalTrials.gov trial register no. NCT.01001026. Abstract

Similar Items